Avidity Partners Management LP Athira Pharma, Inc. Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.24 - $20.87 $17.2 Million - $35 Million	-1,677,845 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.9 - $29.77 $10.7 Million - $18.9 Million	633,972 Added 60.73%	1,677,845 $30.9 Million
Q4 2020 Feb 16, 2021	BUY	$16.48 - $34.3 $288,910 - $601,313	17,531 Added 1.71%	1,043,873 $35.8 Million
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $16.4 Million - $18.9 Million	1,026,342 New	1,026,342 $18.9 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.